5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International …

…, M McLaughlin, SC Morgan, FL Cury… - The Lancet …, 2022 - thelancet.com
Background Stereotactic ablative body radiotherapy (SABR) is a non-invasive treatment option
for primary renal cell carcinoma, for which long-term data are awaited. The primary aim of …

NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer

…, PT Tran, RJ Karnes, RC Chen, FL Cury… - International Journal of …, 2021 - Elsevier
Purpose In 2009, the Radiation Therapy Oncology Group (RTOG) genitourinary members
published a consensus atlas for contouring prostate pelvic nodal clinical target volumes (CTVs)…

Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer

GA Turgeon, L Souhami, FL Cury, SL Faria… - International Journal of …, 2014 - Elsevier
Purpose/Objective(s) To review our experience with bladder-preserving trimodality treatment
(TMT) using hypofractionated intensity modulated radiation therapy (IMRT) for the treatment …

Brachytherapy improves biochemical failure–free survival in low-and intermediate-risk prostate cancer compared with conventionally fractionated external beam …

…, J Crook, AG Martin, E Vigneault, FL Cury… - International Journal of …, 2015 - Elsevier
Purpose To compare, in a retrospective study, biochemical failure-free survival (bFFS) and
overall survival (OS) in low-risk and intermediate-risk prostate cancer patients who received …

Dose-escalated radiotherapy alone or in combination with short-term androgen deprivation for intermediate-risk prostate cancer: results of a phase III multi-institutional …

…, A Currey, VS Kavadi, FL Cury… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE It remains unknown whether or not short-term androgen deprivation (STAD)
improves survival among men with intermediate-risk prostate cancer (IRPC) treated with dose-…

[HTML][HTML] Practical considerations for prostate hypofractionation in the developing world

M Yan, AG Gouveia, FL Cury, N Moideen… - Nature Reviews …, 2021 - nature.com
External beam radiotherapy is an effective curative treatment option for localized prostate
cancer, the most common cancer in men worldwide. However, conventionally fractionated …

Phase 1 trial of atezolizumab plus trimodal therapy in patients with localized muscle-invasive bladder cancer

G Marcq, L Souhami, FL Cury, A Salimi… - International Journal of …, 2021 - Elsevier
Purpose Immune checkpoint programmed death-ligand 1 inhibitor therapy has shown
response in metastatic muscle invasive bladder cancer (MIBC). We evaluated the safety and …

[HTML][HTML] Improving ultrasound-based prostate volume estimation

…, M Luz, F Brimo, E Scarlata, L Hamel, FL Cury… - BMC urology, 2019 - Springer
Background To define a new coefficient to be used in the formula (Volume = L x H x W x
Coefficient) that better estimates prostate volume using dimensions of fresh prostates from …

[HTML][HTML] Biopsychosocial markers of body image concerns in patients with head and neck cancer: a prospective longitudinal study

…, N Sadeghi, K Sultanem, G Shenouda, FL Cury… - Current …, 2022 - mdpi.com
(1) Background: Patients and survivors of head and neck cancer (HNC) are at a high risk of
developing body image concerns. Despite the prevalence of body image concerns in …

[HTML][HTML] Drug costs in the management of metastatic castration-resistant prostate cancer in Canada

A Dragomir, D Dinea, M Vanhuyse, FL Cury… - BMC health services …, 2014 - Springer
Background For Canadian men, prostate cancer (PCa) is the most common cancer and the
3rd leading cause of cancer mortality. Men dying of PCa do so after failing castration. The …